Pharm
Ceftazidime
search
Ceftazidime
, Fortaz, Tazicef
See Also
Third Generation Anti-Pseudomonal Cephalosporin
Ceftazidime-Avibactam
Cephalosporin
Indications
See
Third Generation Anti-Pseudomonal Cephalosporin
Conditions
Gram-Negative, Multi-drug resistant intraabdominal Infections and
Urinary Tract Infection
s
No anaerobic coverage (add
Metronidazole
for abdominal infections)
Pseudomonas
infections
Pseudomonas Osteochondritis
Cystic Fibrosis
lung infection
Ceftazidime
Bacteria
l Coverage
Pseudomonas
aeruginosa (Main indication)
EKP Gram Negative Bacteria
(
Escherichia coli
,
Klebsiella
,
Proteus
)
ESP Gram Negative Bacteria
(
Enterobacter
,
Serratia
,
Providencia
)
Also covers
Citrobacter
species
Gram Positive Cocci
poorly covered
No
Gram Negative Coccobacilli
coverage
Pharmacokinetics
Half-Life Ceftazidime: 2.7 hours (similar for Avibactam)
Ceftazidime is excreted in urine (80-90% unchanged, avibactam is 100% unchanged on excretion)
Adjust dose in
Renal Failure
Dosing
Adult (and age >12 years)
Urinary Tract Infection
s
Give 0.25 to 0.5 g IM or IV every 8 to 12 hours
Mild to Moderate Infections (
Skin Infection
s)
Give 0.5 to 1 g IM or IV every 8 hours
Severe Infections (
Sepsis
, intra-abdominal infection, bone and joint infection,
Neutropenic Fever
)
Give 2 g IV every 8 hours
Pseudomonas
lung infection in
Cystic Fibrosis
Give 30 to 50 mg/kg IV every 8 hours (max 6 g/day)
Renal Dosing
eGFR 31 to 50 ml/min
Give 1 g IV every 12 hours
eGFR 16 to 30 ml/min
Give 1 g IV every 24 hours
eGFR 6 to 15 ml/min
Load 1 g IV, then give 500 mg every 24 hours
eGFR <5 ml/min
Load 1 g IV, then give 500 mg every 48 hours
Hemodialysis
Load 1 g IV, then give 1 g IV after each
Hemodialysis
session
Dosing
Child (age <12 years)
Give 35 to 50 mg/kg IV every 8 hours (every 12 hours in age <1 week)
Use 50 mg/kg in
Meningitis
Maximum: 6 g/day
Safety
Pregnancy Category B
Consider safe in
Lactation
Ceftazidime is excreted in
Breast Milk
Efficacy
Limited spectrum (focused
Gram Negative
bacillus and
Pseudomonas
coverage)
Adverse Effects
Gastrointestinal (
Nausea
,
Vomiting
,
Diarrhea
,
Constipation
)
Dizziness
Anxiousness
Abdominal Pain
Paresthesia
s
CNS toxicity
Associated with high drug levels in renal dysfunction
Resources
Ceftazidime (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22d6534c-4488-48a1-8d78-e2fb908259de
References
Morrison and LoVecchio (2021) Crit Dec Emerg Med 35(1): 28
Type your search phrase here